BIOCIENCIAS: Bª Y CLÍNICA DEL CÁNCER Y MEDIC. TRASLACIONAL
Escuela de doctorado
Elías
Campo Güerri
Publicaciones en las que colabora con Elías Campo Güerri (24)
2023
-
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Leukemia, Vol. 37, Núm. 2, pp. 339-347
-
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
Blood Advances
-
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO
British Journal of Haematology, Vol. 203, Núm. 2, pp. 202-211
2018
-
The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia
Leukemia and Lymphoma, Vol. 59, Núm. 10, pp. 2318-2326
2017
-
Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas
Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 4, pp. 764-769
-
Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group
Leukemia Research, Vol. 63, pp. 85-89
2016
-
Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes
Genes Chromosomes and Cancer, Vol. 55, Núm. 4, pp. 322-327
2015
-
A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact
Leukemia, Vol. 29, Núm. 3, pp. 598-605
-
Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia
Genes Chromosomes and Cancer, Vol. 54, Núm. 11, pp. 668-680
-
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Nature, Vol. 526, Núm. 7574, pp. 519-524
2014
-
Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption
Haematologica
-
Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome
Blood, Vol. 123, Núm. 24, pp. 3790-3796
2013
-
Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group
Annals of Hematology, Vol. 92, Núm. 9, pp. 1151-1179
-
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 45, pp. 18250-18255
-
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome
Leukemia, Vol. 27, Núm. 5, pp. 1100-1106
2012
-
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Nature Genetics, Vol. 44, Núm. 1, pp. 47-52
2011
-
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Nature, Vol. 475, Núm. 7354, pp. 101-105
2010
-
Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma
Genes Chromosomes and Cancer, Vol. 49, Núm. 5, pp. 439-451
-
International network of cancer genome projects
Nature, Vol. 464, Núm. 7291, pp. 993-998
2008
-
New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY)
Leukemia Research, Vol. 32, Núm. 5, pp. 727-736